Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted TAR-200 Breakthrough Therapy Designation (BTD)...
Sittner & Nelson LLC lowered its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.9% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,650 shares of the company’s stock after selling 155 shares during the quarter. Johnson & Johnson […]
Johnson & Johnson completed the previously unheralded acquisition of privately held Laminar Inc. for $400 million upfront, with undisclosed contingent payments depending on achievement of clinical and regulatory milestones starting in 2024. The deal provides the med-tech giant a potentially game-changing entree into the lucrative left atrial appendage (LAA) market.
CNBC's Jim Cramer on Thursday detailed what may be hurting healthcare stocks.
Real-time coverage of Friday's biggest analyst chatter and calls.